“Galectin-3 as a potential marker of myocardial hypertrophy in essential hypertension in individuals with polymorphic AT1R genotypes”, Biomed. Res. Ther., vol. 5, no. 8, pp. 2633–2644, Aug. 2018, doi: 10.15419/bmrat.v5i8.471.